Zepsyre has a path to market at last

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Aug 19, 2019 at 11:22 AM.

  1. #1 cafead, Aug 19, 2019 at 11:22 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,046
    Likes Received:
    3
    via After numerous twists and turns Pharmamar will no longer have to wait for next year’s binary outcome of the pivotal Atlantis trial before filing its small-cell lung cancer project Zepsyre. Instead, based on the just-revealed result of a call with the US FDA, filing for accelerated approval will take place in the fourth quarter.

    article source
     
    Quote

Reply to Thread